Research Topic · Peer-Reviewed

Chloroquine

Chloroquine is a 4-aminoquinoline compound long used as an antimalarial and antirheumatic agent, acting principally as a weak base that accumulates within acidic intracellular compartments and raises endosomal and lysosomal pH. In the malaria parasite this interferes with heme detoxification in the digestive vacuole…

Curated from this journal's research 📚 5 peer-reviewed articles cited Cited 7× across the literature 🔖 ISSN 2692-1537 🗓 Reviewed July 2026

Overview

Chloroquine is a 4-aminoquinoline compound long used as an antimalarial and antirheumatic agent, acting principally as a weak base that accumulates within acidic intracellular compartments and raises endosomal and lysosomal pH. In the malaria parasite this interferes with heme detoxification in the digestive vacuole; in other contexts the same alkalinizing effect impairs endosomal acidification, antigen processing, and autophagy. These properties prompted investigation of chloroquine and its hydroxylated analogue, hydroxychloroquine, as candidate antivirals during the COVID-19 pandemic, on the hypothesis that raised endosomal pH might hinder viral entry and post-entry processing of SARS-CoV-2. Clinical evaluation examined viral kinetics in mild disease treated with chloroquine-containing regimens versus standard of care, and assessed effects on clinical improvement and mortality in hospitalized patients. The drug class carries a defined toxicity profile, notably QT-interval prolongation, retinal injury with prolonged exposure, and gastrointestinal effects, which constrain dosing and demand monitoring. Pharmacologically, chloroquine illustrates how a single mechanism, lysosomotropic accumulation, can underlie activity against unrelated targets spanning protozoal infection, autoimmune inflammation, and viral replication. Research in this area weighs in vitro plausibility against controlled clinical evidence, the central question being whether laboratory activity translates into measurable patient benefit.

Research published in this journal

5 peer-reviewed articles, ranked by relevance. Each links to its DOI.

2020

The Novel Coronavirus 2019 (COVID-19): A Narrative Review

Rezapour BarataliCorresponding author
Department of Public Health, Faculty of Health, Assistant Professor, PhD in Health education and promotion, Urmia University of Medical Sciences, Urmia, Iran
Exact topic International Journal of Coronaviruses Cited by 2 doi:10.14302/issn.2692-1537.ijcv-20-3373
2018

Malaria: An Unseen Enemy Threatening to Mankind

Shende PravinCorresponding author
Shobhaben Pratapbhai Patel School of Pharmacy and Technology Management, SVKM’s NMIMS, Mumbai, India.
Exact topic Tropical Diseases and Medicine

How this research is being cited

The 5 articles above have been cited 7 times in the scholarly literature. Citation data via OpenAlex and Crossref, updated Jun 2026.

A sample of recent works citing this journal's research on Chloroquine, linking to each citing work.

Editorial oversight

Curated from peer-reviewed research published in International Journal of Coronaviruses (ISSN 2692-1537).

Journal editorial board
Dr. Omeed Memar · USA Dr. SUDIPTI GUPTA · United States Dr. Jose Luis Turabian · Spain

This page summarises published research for orientation; it is not medical or professional advice.